RENITEC

Main information

  • Trade name:
  • RENITEC 5 mg tablet
  • Dosage:
  • 5 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • RENITEC 5 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Enalapril
  • Product summary:
  • Suitability for use in older adult patients Enalaprili maleas Suitable for older persons, with specific cautions. Ensure adequate fluid balance before starting treatment. Reduce the dose in moderate and severe renal insufficiency. Monitor renal function during the pharmacotherapy. Significant adverse effects include orthostatic hypotension, especially when starting treatment. Avoid concurrent use of anti-inflammatory analgesics.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 9145
  • Authorization date:
  • 01-11-2009
  • Last update:
  • 26-07-2018